Metabolite analysis of peritoneal dialysis (PD) effluent may provide information regarding onset and progression of complications associated with prolonged PD therapy. In this context, the NMR detectable small metabolites of PD effluent samples were characterized using high resolution C HSQC spectrum were identified specific to various metabolites of PD effluent. We foresee that the characteristic fingerprints of various metabolites of control PD effluent samples will be used to identify and distinguish metabolic differences from PD related complications.
Abstract:
Metabolite analysis of peritoneal dialysis (PD) effluent may provide information regarding onset and progression of complications associated with prolonged PD therapy. In this context, the NMR detectable small metabolites of PD effluent samples were characterized using high resolution 1 H and 1 H- 13 C NMR spectroscopy. The various spectra were recorded (at 800 MHz proton frequency) on PD effluent samples obtained after 4 hour (intraperitoneal) dwell time from patients with end stage renal failure (ESRF) and continuing normally on PD therapy. Inspite of devastating spectral feature of PD effluent due to the presence of intense resonances from glucose and lactate, we were able to identify about 53 small endogenous metabolites (including many complex coupled spin systems) and more than 90 % of the total CH cross peaks of 1 H- 13 C HSQC spectrum were identified specific to various metabolites of PD effluent. We foresee that the characteristic fingerprints of various metabolites of control PD effluent samples will be used to identify and distinguish metabolic differences from PD related complications.
Introduction:
Peritoneal dialysis (PD) is used for treating patients with end-stage renal failure (ESRF). Though, PD gives more freedom compared to haemodialysis, it is often associated with a number of complications which could be either immediate or delayed [1] [2] [3] [4] [5] [6] [7] [8] . These have broadly been classified into two categories based on their aetiologies: (a) infectious including bacterial, tuberculous, fungal, and infections of the catheter exit site and tunnel and (b) non-infectious including catheter failure, peritoneum damage (caused by PD fluids rendering it unsuitable for adequate dialysis), hernias and encapsulating peritoneal sclerosis (EPS, a rare but serious complication) [2] [3] [4] . If not diagnosed and treated at an early stage, these clinical complications can lead to permanent malfunctioning of peritoneal membrane -the condition commonly referred to as peritonitis-which is probably the most common cause of morbidity in patients treated with this modality. It is also the major cause of technique failure and transfer of patients to haemodialysis (HD), either temporarily or permanently [5, 6] . As the number of ESRF patients continuing on PD therapy is increasing every year and generally they remain on PD for more than 2-5 years [7] , the peritonitis episodes are becoming more and more evident. Therefore, an efficient method for rapid and early detection of PD-related complications and subsequent recovery is needed [5, 6] .
For such a purpose, it appears valuable to analyse the PD effluent in a rapid and non-invasive manner. Further, the quantitative biochemical information on PD effluent evaluated over a period of time during the start of the therapy can be used to assess the success of PD therapy and functionality of peritoneal membrane. NMR spectroscopy is ideally suited for identifying biochemical changes [9] [10] [11] [12] [13] [14] [15] .
Particular advantage of NMR is that it gives qualitative and quantitative information about the endogenous metabolites. The quantitative measurements of major NMR signals are used to detect metabolic up-regulations/down-regulations. Other advantage of NMR is that it requires little or no sample preparation and usually a metabolite concentration of greater than a few M is detectable in 1 H NMR spectra in a reasonable amount of time ( 1 H NMR; 128 scans; approximately 15 min) [10] , therefore, it provides a better non-invasive predictive measure along with the benefit of rapidity in diagnosis.
So far, no NMR based study on PD effluent seems to have been reported in the context of predicting complications associated with prolonged PD therapy. This prompted us to explore the utility of NMR spectroscopy in the diagnosis and prognosis PD related complications. Like any other body fluid (e.g. urine, serum, bile, synovial fluid, cerebrospinal fluid etc.), PD effluent is a complex mixture of hundreds of small metabolites. In order to derive any reliable and meaningful clinical information from metabolome analysis of PD effluent, the very first and essential requirement is to identify and assign as many metabolites as possible. However, the 1 H NMR based analysis of a complex mixture like PD effluent is severely hampered by spectral complexity and signal overlap. In case of PD effluent, the spectral quality is further impaired by the presence of intense resonances from unused Glucose and Lactate (the major constituents of PD fluid). In order to overcome the spectral complexity and congestion, we used high field instrument along with two-dimensional (2D) J-resolved (JRES), H NMR spectrum [16] [17] [18] [19] .
Once the metabolites are identified and their 1 H and 13 C NMR signals are assigned, the data provide useful baseline information to assess the feasibility of NMR for clinical studies.
Materials and Method: Collection of PD Effluent Samples:
The PD effluent samples (12 episodes) used in this study were obtained from 8 PD patients (n=8) admitted in the Nephrology wards of Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow. The study protocol was approved by the Hospital's Research Committee. All selected PD patients involved in this study (n=8) were continuing normally on the PD therapy (as confirmed according to the guidelines of International Society of Peritoneal Dialysis) [5, 6] . The main exclusion criterion was the presence of infectious disease and cloudy effluent with turbidity. All were instilled (into their peritoneal cavity) with PD solutions containing dextrose (2.5 %, Dianeal, Baxter Healthcare). In each case, PD effluent sample was collected after a 4 hour dwell time, and was frozen and stored at a temperature of -80 C, within 1-2 hours (to preserve the metabolic snapshot in the most optimal way [9] ) until the NMR measurements were performed. Prior to NMR data collection, all samples were thawed and centrifuged to remove precipitates. 
NMR Spectroscopy and Assignment:
All NMR spectra were recorded at 298 K on Bruker Avance III 800 MHz NMR spectrometer (equipped with Cryoprobe) using the Bruker's standard pulse program library. One-dimensional 1 H-NMR spectra were recorded on all the available PD effluent samples using the Carr-Purcell-MeiboomGill (CPMG) pulse sequence (cpmgpr1d) with pre-saturation of the water peak [13] . Each spectrum consisted of the accumulation of 128 scans with a recycle delay (RD) of 5 sec and lasted for approximately 15 minutes. To remove broad signals from triglycerides, proteins, cholesterols and phospholipids, a total spin-spin relaxation time of 160 ms (n=400 and 2τ=400 s) was used which allowed a better detection of H NMR spectra were also recorded using the bipolar pulse longitudinal eddy current delay (BPPLED) pulse sequence [20] . The square gradients of 70% of the maximum gradient strength (56 G/cm) and 2 ms duration (followed by a delay of 200 s to allow for the decay of eddy currents) were used. Diffusion time of 120 ms was used to attenuate the signals from low molecular weight compounds without affecting the lipid signals. All the spectra or FIDs (free induction decays) were processed in Topspin-2.1 (Bruker NMR data Processing Software) using standard Fourier Transformation (FT) procedure following manual phase and baseline-correction. Prior to FT, each FID was zero-filled to 4096 data points and a sine-bell apodisation function was applied. After FT, the chemical shifts were referenced externally to TSP methyl protons at 0.0 ppm. properties (especially the bulk diamagnetic susceptibility). However among all, PD effluent is found to share proximate composition with urine; apparently because it also contains metabolites consumed from and secreted into the intraperitoneal dialysis fluid from the tissue or cells in close proximity [7, 27] . Like urine, the 1D 
Spectral Assignment:
Prior to resonance assignments all the spectra's were referenced with respect to the methyl (CH 3 ) group of TSP at 0 ppm both for Figures 2a, 2b and 2c , respectively. At about 0.83 ppm a sharp doublet due to γ-CH 3 moiety of 2-hydroxy-3-methylbutyric acid was observed which was followed by triplet due to CH 3 group of 2-hydroxybutyric acid at 0.90 ppm. A doublet due to γ-CH 3 group of valine was observed at about 0.99 ppm followed by two doublets due to δ-CH 3 group of isoleucine and γ-CH 3 groups of valine at 1.01 and 1.04 ppm, respectively. A triplet due to CH 3 group of ethanol was observed at 1.18 ppm which is slightly overlapped with a doublet due to γ-CH 3 moiety of 3-Hydroxybutyric acid at 1.20 ppm. A large intensity doublet was observed at 1.33 ppm due to CH 3 group of lactate followed by a doublet due to methyl group of alanine at 1.47 ppm. Similarly singlets due to methyl group of acetic acid and CH 2 group of oxalacetic acid were observed at 1.92 and 2.37 ppm, respectively. Severe spectral congestion and signal overlap was seen in the regions, 1.6-1.92 ppm, 1.97-2.15 ppm, 2.29-2.47 ppm and 2.99-3.03 ppm due to complex multiplet overlapped by resonances from other metabolites which were assigned using TOCSY and HSQC spectra. The methyl groups of acetone and acetoacetate produce singlets at 2.23 and 2.28 ppm, respectively. Two doublets due to CH 2 groups of citric acid were observed at 2.52 and 2.69 ppm followed by a singlet at 2.73 ppm due to methyl group of dimethylamine. A singlet due to CH 3 group of creatinine was also observed at 3.04 ppm. In the high frequency region, we see a broad singlet at 5.78 ppm due to NH 2 group of urea. Two doublets due to C2H & C6H rings of tyrosine and tyramine were observed at 6.86 and 6.89 ppm, respectively, followed by a singlet at 7.05 ppm due to C4H-ring of histidine. A singlet at 7.77 ppm due to C2H-ring of histidine followed by a doublet at 7.83 ppm due to o-CH group of hippurate and a singlet at 8.45 ppm due to CH group of formic acid was observed.
In order to achieve detailed spectral assignment in the complex and highly overlapped regions, the information provided by 1D CPMG spectra was combined with 2D J-resolved (JRES), Table S1 . Some observed chemical shifts differ from expected database values, probably due to a difference in bulk diamagnetic susceptibility. Overall, a significant similarity was found in the metabolic composition of PD effluent and that of human urine. Table  S1 . As evident, the HSQC spectrum exploits the generally good dispersion of 13 C chemical shifts on one axis of the 2D spectrum, thus provides increased resolution and greater specificity for unambiguous resonance assignment of metabolites.
Concluding Remarks:
This study reports the characterization of metabolites in PD effluent using high-resolution 1D/2D NMR spectroscopy. We foresee that the spectral fingerprints established here for various metabolites of PD effluent may be used for detecting/predicting the complications associated with prolonged peritoneal dialysis through identifying and differentiating metabolic differences between normal and affected PD effluent samples. Such studies are in progress. Figure S1 . Stack plot of representative one-dimensional 1 H NMR spectrum of PD effluent samples obtained after 4 hour dwell time from PD patients continuing normally on PD therapy: (A) standard spectrum (zgesgp from Bruker library with water suppression using excitation sculpting with gradients) and (B) CPMG spin-echo spectrum (cpmgpr1d from Bruker library with T2 filter using Carr-Purcell-Meiboom-Gill sequence and water suppression using presaturation). Like urine, the 1D 1 H NMR spectra of PD effluent showed sharp (narrow linewidths and adequate signal-to-noise ratios) peaks of low molecular weight metabolites with well-resolved spinspin multiplicities. As evident from standard 1D 1 H NMR spectra (A), these peaks are superimposed on broader signals arising mainly from proteins and phospholipids. Two-dimensional COSY (cosygpprqf) and TOCSY (dipsi2esgpph) proton-proton correlation spectra were acquired, respectively, in magnitude and phase sensitive mode using time proportional phase incrementation (TPPI). In each case, 2048 data points along direct dimension (F 2 ) and 512 increments along indirect dimension (F 1 ) were acquired with 16 transients per increment and a spectral width of 12 ppm in both dimensions. The FIDs were weighted using a sine-bell-squared function in both dimensions and zero filled to 2048 and 4096 data points, respectively, in the F 1 and F 2 dimensions prior to FT. For COSY experiment, the RD between successive pulse sequence cycles was 1.5 sec, while for TOCSY experiment (with mixing time of 80 ms), the RD between successive pulse cycles was 3.0 sec. Spin-lock was achieved by a DIPSI2 pulse sequence train [33] during the TOCSY mixing time. C decoupling during acquisition using GARP-1 [33] . A RD of 2.0 sec was used between successive pulse sequence cycles and a refocusing delay equal to 1/(4* Table S1 . Figure S7 . 2D 1 H-1 H TOCSY spectrum of PD effluent in the high frequency region 5.8-9.2 pap (fitted with standard CPMG 1 H NMR sub-spectra on its sides). The labels for the cross-peaks represent the metabolite as per the assignment listed in Table S1 . 
